Top

Published in:

01-02-2015 | Cardiac Radiology

Cardiac MR perfusion imaging: where we are

Authors: Riccardo Marano, Luigi Natale, Amedeo Chiribiri, Federica Pirro, Valentina Silvestri, Giuseppe Coppola, Lorenzo Bonomo

Published in: La radiologia medica | Issue 2/2015

Abstract

To date, several clinical and multicentre studies have demonstrated the accuracy of perfusion cardiac magnetic resonance to detect ischaemia in comparison with quantitative coronary angiography, other noninvasive diagnostic techniques (single photon emission computed tomography; positron-emission tomography), and invasive haemodynamic measurements (fractional flow reserve). Moreover, the favourable safety profile and increasing availability contribute to make perfusion cardiac magnetic resonance one of the modalities of choice for the detection of myocardial ischaemia. Recently, the first evidence of the prognostic value of perfusion cardiac magnetic resonance results has also become available. This review summarises the technical and interpretation key points of perfusion cardiac magnetic resonance scan, the clinical indications, the most recent available literature about its diagnostic performance and prognostic value, and how perfusion cardiac magnetic resonance compares with other noninvasive techniques.

Kim HW, Klem I, Kim RJ (2007) Detection of myocardial ischemia by stress perfusion cardiovascular magnetic resonance. Magn Reson Imaging Clin N Am 15:527–540CrossRefPubMed

Araujo LI, Lammertsma AA, Rhodes CG et al (1991) Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen 15 labeled carbon dioxide inhalation and positron emission tomography. Circulation 83:875–885CrossRefPubMed

Gould KL, Kirkeeide RL, Buchi M (1990) Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 15:459–474CrossRefPubMed

Gould K (1978) Noninvasive assessment of coronary stenosis by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol 41:267–278CrossRefPubMed

Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474CrossRefPubMed

Bartunek J, Sys SU, Heyndrickx GR et al (1995) Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. J Am Coll Cardiol 26:328–334CrossRefPubMed

Pijls NH, De Bruyne B, Peels K et al (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334:1703–1708CrossRefPubMed

Atkinson DJ, Burstein D, Edelman RR (1990) First-pass cardiac perfusion: evaluation with ultrafast MR imaging. Radiology 174:757–762CrossRefPubMed

Manning WJ, Atkinson DJ, Grossman W et al (1991) First-pass nuclear magnetic resonance imaging using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 18:959–965CrossRefPubMed

10.

Schwitter J, Nanz D, Kneifel S et al (2001) Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103:2230–2235CrossRefPubMed

11.

Schwitter J, Wacker CM, van Rossum AC et al (2008) MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 29:480–489CrossRefPubMed

12.

Sakuma H, Suzawa N, Ichikawa Y et al (2005) Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am J Roentgenol 185:95–102CrossRefPubMed

13.

Wagner A, Mahrholdt H, Holly TA et al (2003) Contrast-enhanced MRI and routine single-photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361:374–379CrossRefPubMed

14.

Greenwood JP, Maredia N, Younger JF et al (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379:453–460CrossRefPubMedCentralPubMed

15.

Schwitter J, Wacker CM, Wilke N et al (2013) MR-IMPACT II: magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. MR-IMPACT Investigators. Eur Heart J 34:775–781CrossRefPubMed

16.

Jerosch-Herold M (2010) Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 12:57CrossRefPubMedCentralPubMed

17.

Ishida M, Schuster A, Morton G et al (2011) Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 13:28CrossRefPubMedCentralPubMed

18.

Wilke N, Jerosch-Herold M, Wang Y et al (1997) Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 204:373–384CrossRefPubMed

19.

Hundley WG, Bluemke DA, Finn JP et al (2010) ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 121:2462–2508CrossRefPubMed

20.

Di Cesare E, Cademartiri F, Carbone I et al (2013) Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging. Radiol Med 118:752–798CrossRefPubMed

21.

Shryock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79:2–10CrossRefPubMed

22.

Hundley WG, Hamilton CA, Thomas MS et al (1999) Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100:1697–1702CrossRefPubMed

23.

Lanza GA, Buffon A, Sestito A et al (2008) Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol 51:466–472CrossRefPubMed

24.

Iskandrian AE, Bateman TM, Belardinelli L et al (2007) Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 14:645–658CrossRefPubMed

25.

Al Jaroudi W, Iskandrian AE (2009) Regadenoson: a new myocardial stress agent. J Am Coll Cardiol 54:1123–11230CrossRefPubMed

26.

Reyes E, Staehr P, Olmsted A et al (2011) Effect of body mass index on the efficacy, side effect profile, and plasma concentration of fixed-dose regadenoson for myocardial perfusion imaging. J Nucl Cardiol 18:620–627CrossRefPubMed

27.

Leaker BR, O’Connor B, Hansel TT et al (2008) Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol 15:329–336CrossRefPubMed

28.

Thomas GS, Tammelin BR, Schiffman GL et al (2008) Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (regcopd trial). J Nucl Cardiol 15:319–328CrossRefPubMed

29.

Zhao G, Messina E, Xu X et al (2007) Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist. J Cardiovasc Pharmacol 49:369–375CrossRefPubMed

30.

www.fda.gov [Lexiscan (regadenoson) and Adenoscan (adenosine): Drug Safety Communication—rare but serious risk of heart attack and death (posted 20/11/2013])

31.

Kramer CM, Barkhausen J, Flamm SD et al (2008) Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 10:35CrossRefPubMedCentralPubMed

32.

Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed

33.

Klem I, Heitner JF, Shah DJ et al (2006) Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 47:1630–1638CrossRefPubMed

34.

Tsao J, Boesiger P, Pruessmann KP (2003) k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn Reson Med 50:1031–1042CrossRefPubMed

35.

Plein S, Ryf S, Schwitter J, Radjenovic A, Boesiger P, Kozerke S (2007) Dynamic contrast- enhanced myocardial perfusion MRI accelerated with k-t SENSE. Magn Reson Med 58:777–785CrossRefPubMed

36.

Plein S, Schwitter J, Suerder D et al (2008) k-space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T. Radiology 249:493–500CrossRefPubMedCentralPubMed

37.

Lockie T, Ishida M, Perera D et al (2011) High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 57:70–75CrossRefPubMed

38.

Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P (1999) SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42:952–962CrossRefPubMed

39.

Cheng AS, Pegg TJ, Karamitsos TD et al (2007) Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol 49:2440–2449CrossRefPubMed

40.

Araoz PA, Glockner JF, McGee KP et al (2005) 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson 7:559–564CrossRefPubMed

41.

Theisen D, Wintersperger BJ, Huber A et al (2007) Myocardial perfusion imaging with Gadobutrol: a comparison between 3 and 1.5 Tesla with an identical sequence design. Invest Radiol 42:499–506CrossRefPubMed

42.

Di Bella EVR, Parker DL, Sinusas AJ (2005) On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Magn Reson Med 54:1295–1299CrossRefPubMedCentralPubMed

43.

Morton G, Chiribiri A, Ishida M et al (2012) Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography. J Am Coll Cardiol 60:1546–1555CrossRefPubMed

44.

Patel AR, Antkowiak PF, Nandalur KR et al (2010) Assessment of advanced coronary artery disease. J Am Coll Cardiol 56:561–569CrossRefPubMedCentralPubMed

45.

Nandalur KR, Dwamena BA, Choudhri AF et al (2007) Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 50:1343–1353CrossRefPubMed

46.

Hamon M, Fau G, Née G et al (2010) Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 12:29CrossRefPubMedCentralPubMed

47.

de Jong MC, Genders TSS, van Geuns RG et al (2012) Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis. Eur Radiol 22:1881–1895CrossRefPubMedCentralPubMed

48.

Cury RC, Cattani CA, Gabure LA et al (2006) Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology 240:39–45CrossRefPubMed

49.

Pilz G, Klos M, Ali E, Hoefling B, Scheck R, Bernhardt P (2008) Angiographic correlations of patients with small vessel disease diagnosed by adenosine-stress cardiac magnetic resonance imaging. J Cardiovasc Magn Reson 10:8CrossRefPubMedCentralPubMed

50.

Rieber J, Huber A, Erhard I et al (2006) Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J 27:1465–1471CrossRefPubMed

51.

Kuhl HP, Katoh M, Buhr C et al (2007) Comparison of magnetic resonance perfusion imaging versus invasive fractional flow reserve for assessment of the hemodynamic significance of epicardial coronary artery stenosis. Am J Cardiol 99:1090–1095CrossRefPubMed

52.

Costa MA, Shoemaker S, Futamatsu H et al (2007) Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol 50:514–522CrossRefPubMed

53.

Ishida N, Sakuma H, Motoyasu M et al (2003) Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 229:209–216CrossRefPubMed

54.

Paetsch I, Jahnke C, Wahl A et al (2004) Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 110:835–842CrossRefPubMed

55.

Manka R, Jahnke C, Gebker R et al (2011) Head-to-head comparison of first-pass MR perfusion imaging during adenosine and high-dose dobutamine/atropine stress. Int J Cardiovasc Imaging 27:995–1002CrossRefPubMed

56.

Di Cesare E, Carbone I, Carriero A et al (2012) Clinical indications for cardiac computed tomography. From the Working Group of the Cardiac Radiology Section of the Italian Society of Medical Radiology (SIRM). Radiol Med 117:901–938CrossRefPubMed

57.

Bettencourt N, Chiribiri A, Schuster A et al (2013) Direct comparison of cardiac magnetic resonance and multidetector computed tomography stress-rest perfusion imaging for detection of coronary artery disease. J Am Coll Cardiol 61:1099–1107CrossRefPubMed

58.

Schuhbäck A, Marwan M, Cury RC et al (2013) Current status of cardiac CT for the detection of myocardial ischemia. Herz 38:359–366CrossRefPubMed

59.

Ingkanisorn WP, Kwong RY, Bohme NS et al (2006) Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 47:1427–1432CrossRefPubMed

60.

Jahnke C, Nagel E, Gebker R et al (2007) Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115:1769–1776CrossRefPubMed

61.

Pilz G, Jeskea A, Klos M et al (2008) Prognostic value of normal adenosine stress cardiac magnetic resonance imaging. Am J Cardiol 101:1408–1412CrossRefPubMed

62.

Lubbers DD, Rijlaarsdam-Hermsen D, Kuijpers D et al (2012) Performance of adenosine “stress-only” perfusion MRI in patients without a history of myocardial infarction: a clinical outcome study. Int J Cardiovasc Imaging 28:109–115CrossRefPubMedCentralPubMed

63.

Nagel E, Klein C, Paetsch I et al (2003) Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108:432–437CrossRefPubMed

64.

Takase B, Nagata M, Kihara T et al (2004) Whole-heart dipyridamole stress first-pass myocardial perfusion MRI for the detection of coronary artery disease. Jpn Heart J 45:475–486CrossRefPubMed

65.

Plein S, Radjenovic A, Ridgway JP et al (2005) Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology 235:423–430CrossRefPubMed

66.

Pilz G, Bernhardt P, Klos M et al (2006) Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin Res Cardiol 95:531–538CrossRefPubMed

67.

Greenwood JP, Younger JF, Ridgway JP et al (2007) Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart 93:1363–1368CrossRefPubMedCentralPubMed

68.

Seeger A, Doesch C, Klumpp B et al (2007) MR stress perfusion for the detection of flow-limiting stenoses in symptomatic patients with known coronary artery disease and history of stent implantation. Rofo 179:1068–1073CrossRefPubMed

69.

Giang TH, Nanz D, Coulden R et al (2004) Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 25:1657–1665CrossRefPubMed

70.

Wolff SD, Schwitter J, Coulden R et al (2004) Myocardial first pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation 110:732–737CrossRefPubMed

Title: Cardiac MR perfusion imaging: where we are
Authors: Riccardo Marano
Luigi Natale
Amedeo Chiribiri
Federica Pirro
Valentina Silvestri
Giuseppe Coppola
Lorenzo Bonomo
Publication date: 01-02-2015
Publisher: Springer Milan
Published in: La radiologia medica / Issue 2/2015
Print ISSN: 0033-8362
Electronic ISSN: 1826-6983
DOI: https://doi.org/10.1007/s11547-014-0435-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cardiac MR perfusion imaging: where we are

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2015

Transvaginal ultrasound assessment of uterine scar after previous caesarean section: comparison with 3T-magnetic resonance diffusion tensor imaging

Blunt abdominal trauma: role of contrast-enhanced ultrasound (CEUS) in the detection and staging of abdominal traumatic lesions compared to US and CE-MDCT

Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?

2014 Scientific Referees

Treatment of urological complications in more than 1,000 kidney transplantations: the role of interventional radiology

Relationship between CT volumetric measurements and Doppler perfusion indices in gastrointestinal liver metastasis